1 completed, 1 recruiting, 1 terminated, 1 withdrawn. 4 Phase 2, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 1, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 3 | 4 | Completed 1, Recruiting 1, Terminated 1, Withdrawn 1 |
Follow Fertility Issues: new trials by email Literature Review of Fertility Issues trials Research Report on Fertility Issues
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia Intensive Lifestyle Intervention (ILI), Megestrol Acetate 160 MG Oral Tablet, Levonorgestrel-Releasing Intrauterine Contraceptive System (Mirena), 52 Mg - Atypical Endometrial Hyperplasia, Fertility Issues | Phase 2 / Phase 3 | Recruiting | Xiaojun Chen | 172 | 2022-06-13 | 2026-06-04 |
| Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma Intensive Lifestyle Intervention (ILI), Megestrol Acetate 160 MG Oral Tablet - Endometrial Carcinoma, Obese | Phase 2 / Phase 3 | Terminated | Xiaojun Chen | 8 | 2022-05-01 | 2026-06-04 |
| Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia levonorgestrel-releasing intrauterine system, Polyethylene Glycol Loxenatide - Atypical Endometrial Hyperplasia, Obesity | Phase 2 / Phase 3 | Completed | Fudan University | 30 | 2022-01-08 | 2026-03-13 |
| Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia Liraglutide Injection, Megestrol Acetate 160 MG - Atypical Endometrial Hyperplasia, Obese | Phase 2 / Phase 3 | Withdrawn | Xiaojun Chen | 2021-03-20 | 2024-09-26 |
Infertility (4) · Obesity (4) · Endometrial Hyperplasia (3) · Overweight (2) · Endometrial Neoplasms (1)
Body Weight (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Nutrition Disorders (4) · Nutritional and Metabolic Diseases (4) · Overnutrition (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Urogenital Diseases (4) · Uterine Diseases (4) · Overweight (2) · Genital Neoplasms, Female (1) · Neoplasms (1)
Megestrol Acetate (3) · Tablets (2) · Levonorgestrel (1) · Liraglutide (1) · polyethylene glycol loxenatide (1)
Xiaojun Chen (3) · Fudan University (1)
China (3)